Table 1

Baseline characteristics of study participants based on hypertriglyceridemic waist phenotypes

Group 1Group 2Group 3
n18230127
Age (years)67 ± 10*61 ± 860 ± 7
BMI (kg/m2)24.7 ± 2.833.0 ± 4.932.5 ± 4.6
Waist circumference (cm)81.4 ± 5.0109.1 ± 12.0108.6 ± 10.9
Duration of type 2 diabetes (months)121 ± 15994 ± 8386 ± 79
A1C (%)7.0 ± 0.87.3 ± 0.97.6 ± 1.1
Sex (%)
    Men396165
    Women613935
Smoking (%)
    Current171515
    Former504854
    Never333731
Diabetes therapy (%)
    None111221§
    Sulfonylurea171615
    Metformin282536§
    Sulfonylurea and metformin223425§
    Insulin22133§
Statin use (%)
    On statin505360
    No statin504740
  • Data are means ± SD or percent. Group 1 (low waist circumference and low triglycerides; waist circumference ≤90 cm in men or ≤85 cm in women and triglycerides <177 mg/dl); group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230); and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglyceride ≥177 mg/dl, n = 127).

  • *P < 0.05 vs. groups 2 and 3;

  • P < 0.0001 vs. group 1;

  • P < 0.01 vs. groups 1 and 2;

  • §P < 0.01 vs. group 2.